Inotiv, Inc. Stock Deutsche Boerse AG
Stocks
BS50
US45783Q1004
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 387K 340K 316K 290K 545K 37.29M 554K 3.76M 1.47M 18.33M 1.45M 1.42M 63.39M | P/E 2024 |
-0.41x | P/E 2025 | -0.69x |
|---|---|---|---|---|---|
| Enterprise Value | 438M 385M 358M 328M 617M 42.17B 626M 4.25B 1.66B 20.73B 1.64B 1.61B 71.69B | EV / Sales 2024 |
0.95x | EV / Sales 2025 | 0.95x |
| Free-Float |
93.32% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Inotiv, Inc.
| 1 day | -10.42% | ||
| 3 months | -80.80% | ||
| 6 months | -89.66% | ||
| Current year | -89.95% |
| Current year | 0.02 |  | 0.52 |
| 1 year | 0.02 | | 1.9 |
| 3 years | 0.02 | | 10.1 |
| 5 years | 0.02 | | 52.5 |
| 10 years | 0.02 | | 52.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Leasure
CEO | Chief Executive Officer | 67 | 2019-01-11 |
Beth Taylor
DFI | Director of Finance/CFO | 61 | 2020-03-05 |
Andrea Castetter
CMP | Compliance Officer | 49 | 2023-10-22 |
| Director | Title | Age | Since |
|---|---|---|---|
R. Neff
CHM | Chairman | 71 | 2024-03-25 |
John Sagartz
BRD | Director/Board Member | 60 | 2018-07-01 |
Robert Leasure
BRD | Director/Board Member | 67 | 2019-01-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.42% | -.--% | - | - | 387K | |
| +1.07% | -3.49% | -3.35% | +10.44% | 46.86B | |
| +0.25% | +1.65% | +399.22% | +634.87% | 40.23B | |
| -0.27% | +4.45% | +11.81% | +65.64% | 36.23B | |
| +0.35% | +0.87% | +4.46% | -10.16% | 34.72B | |
| +3.14% | +1.02% | +4.76% | +40.92% | 27.89B | |
| -0.73% | +11.84% | +34.39% | +134.36% | 16.79B | |
| +0.47% | -2.74% | - | - | 16.74B | |
| +0.42% | -5.52% | -3.43% | +9.03% | 13.12B | |
| -2.68% | -2.49% | -11.36% | -33.61% | 12.7B | |
| Average | -0.84% | +0.83% | +54.56% | +106.44% | 27.25B | |
| Weighted average by Cap. | +0.48% | +0.91% | +74.42% | +136.27% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 491M 431M 401M 368M 691M 47.26B 702M 4.76B 1.86B 23.23B 1.84B 1.8B 80.33B | 513M 451M 419M 385M 722M 49.4B 734M 4.98B 1.94B 24.29B 1.93B 1.88B 83.98B |
| Net income | -108M -95.25M -88.58M -81.28M -153M -10.44B -155M -1.05B -411M -5.13B -407M -398M -17.75B | -68.62M -60.27M -56.05M -51.44M -96.64M -6.61B -98.13M -666M -260M -3.25B -258M -252M -11.23B |
| Net Debt | 424M 372M 346M 318M 597M 40.8B 606M 4.11B 1.61B 20.06B 1.59B 1.56B 69.36B | 438M 384M 357M 328M 616M 42.14B 626M 4.24B 1.66B 20.72B 1.64B 1.61B 71.62B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
